Several specialized firms worldwide focus on the manufacture of complex medicinal APIs, notably Abacavir sulfate, Abarelix, and Abiraterone Mesylate. These compounds present significant hurdles in synthetic development due to their structural sophistication. The manufacturers of these APIs often employ specialized methods and adhere to strict regul